ERBB2 and neoplasm: Similar to Foxp3 expression in BC [5], upregulation of CCL22 expression in tumor cells was significantly more common in carcinomas with unfavorable histological features, such as high tumor grade, ER-negativity, PR-negativity and HER2-overexpression.